Pyongyang, June 7 (KCNA) — According to Rodong Sinmun, a research group of the Biomedicine Institute under the Academy of Medical Science in the DPRK developed an immune injection helpful to stabilizing blood pressure of hypertensive patients.

This injection, unlike ordinary depressants, can keep blood pressure stable for a month or two with a single injection and thus hypertensive patients reduce the burden of daily use of medications, while suppressing fluctuations in blood pressure.